Current and Emerging Targeting Strategies for Treatment of Pancreatic Cancer.

Baines, A T; Martin, P M; Rorie, C J

Baines, A T; Martin, P M; Rorie, C J.

Afiliação

Baines AT; Cancer Research Program, JLC-Biomedical/Biotechnology Research Institute, North Carolina Central University, Durham, NC, United States; School of Medicine, UNC-Chapel Hill, Chapel Hill, NC, United States. Electronic address: abaines@nccu.edu.
Martin PM; North Carolina Agricultural and Technical State University, Greensboro, NC, United States.
Rorie CJ; North Carolina Agricultural and Technical State University, Greensboro, NC, United States.

Prog Mol Biol Transl Sci ; 144: 277-320, 2016.

Article em En | MEDLINE | ID: mdl-27865460

Assuntos

Terapia de Alvo Molecular/tendências; Neoplasias Pancreáticas/terapia; Animais; Antineoplásicos/uso terapêutico; Quimioprevenção; Epigênese Genética; Humanos; Imunoterapia; Neoplasias Pancreáticas/genética; Neoplasias Pancreáticas/prevenção & controle

Palavras-chave

Cancer vaccine; Immune checkpoint inhibitors; Kinase inhibitors; Monoclonal antibodies; Pancreatic cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Terapia de Alvo Molecular Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google